Co-founder and CEO
Bitome Inc.
Boston Massachusetts UNITED STATES
Herb Ryan is co-founder and CEO of Bitome Inc., a venture-backed pre-clinical digital therapeutic company developing a noninvasive approach to assessing volume status in patients diagnosed with cardiorenal syndrome. Before Bitome, Herb spent a decade in academic and industry R&D managing high impact research efforts to develop breakthrough analytical tools for probing the next frontier in omics: the human metabolome. Herb has authored over 30 peer reviewed manuscripts and pending/issued patents in the areas of microsystem technology, medical physics, biomaterial development, transcriptomics, and systems biology. Herb and Bitome are currently in-residence at Bayer LifeHub in Boston as part of a first ever fellowship. Noteworthy speaking engagements include: • University of Massachusetts Medical Device Development Center (M2D2) $200K Challenge (April 2018) • TECH PLANTER Boston (2017) • MassMedic pitch competition (2017) • BBraun/Venture Cafe pitch competition (2017) • NASA iTech Cycle II (2017) • MIT Enterprise Forum startup showcase (2016) • Meeting of the Harvard Biotech Journal Club (2016) Sample video: https://blogs.uml.edu/m2d2/2018/04/11/2018-m2d2-200k-challenge-winners-announced/ https://www.youtube.com/watch?v=zH9N7za0Rhs